Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
Belgian scientists identify ATP10B as novel risk gene for Parkinson's disease
Screening DNA of Parkinson's patients in the Christine Van Broeckhoven laboratory (VIB-UAntwerpen Center for Molecular Neurology) identified a new risk gene for Parkinson's disease.
Mylan prepares hydroxychloroquine giveaways after production ramp-up
Mylan is one of a group of drugmakers that have joined the global effort to supply doses of generic hydroxychloroquine, an antimalarial touted as a possible COVID-19 therapy, to ongoing clinical trial...
Johnson & Johnson posts 'temporary' Tylenol shortage amid heightened demand
With anxiety about the U.
China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data
China's CanSino Bio is the first in the world to advance a COVID-19 vaccine into phase 2 testing.
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis
PRINCETON, NJ, USA - March 26, 2020 - Bristol-Myers Squibb Company (NYSE.
BeiGene's supply of Bristol Myers Squibb's Abraxane freezes in China amid Fresenius Kabi plant woes
It’s not very often you hear about manufacturing problems at Western facilities slammed by Chinese authorities.
Jefferies pumping $10M into ApiJect and HHS' national syringe 'surge' network
A company set up to provide safe, cheap prefilled syringes to developing countries is turning its expertise loose on the U.
Labeling of cannabidiod products becoming a public health concern
New Rochelle, NY, March 25, 2020--The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue.
Bayer enlists Curadev in STING antagonist collaboration
Bayer and Curadev have announced a novel research collaboration and license agreement for Curadev’s Stimulator of Interferon Genes (STING) antagonist program.
QIAGEN Releases QIAstat-Dx Test Kit to the U.S. as First Syndromic Test for Detection of SARS-CoV-2 Coronavirus Under New FDA Policy
QIAGEN (NYSE.
India bans export of drug being tested for coronavirus treatment
NEW DELHI (Reuters) - India said on Wednesday it had banned the export of hydroxychloroquine and formulations of the malaria drug while experts test its efficacy in helping treat patients infe...
Venclexta/Venclyxto combo extends myeloid leukaemia survival
Roche has announced that its Phase III VIALE-A study, evaluating Venclexta/Venclyxto (venetoclax) in combination with azacitidine for acute myeloid leukaemia (AML), has met its dual pr...
53
54
55
56
57
58
59
60
61
